What happened, in timestamp order
- Retained observationGroup activity qualified live
100% breadth · Extreme activity
MARKET-DISCOVERED GROUP
3 of 4 measured session-normalized paths align to the downside across 3.1 effective names. Capital-flow agreement is 32%, so the basket is not yet clean. No verified headline preceded the measured move.
100% breadth · Extreme activity
Observed movement is balanced across 3.1 effective names. LQD represents 37.8% of absolute path energy; 3 of 4 members align with the down relative path.
01 · WHAT IS HAPPENING
Observed member paths normalized to the session. The dashed marker shows when the median move first cleared a material threshold; shading marks the latest 20% of the observed window.
02 · WHY IT MATTERS
No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.
No high-confidence shared filing driver is available. The market relationship is observed, but the cause remains unexplained.
No qualified cross-asset lead/lag link is available for this group.
Filing-linked outsiders test whether the move is spreading beyond the established cohort.
No high-confidence filing-linked outsiders are available for this group yet.
03 · WHO IS IN IT
4/4 active0 rising · 4 falling
| TICKER | Company | Role now | Today | Observed history | Trader interpretation |
|---|---|---|---|---|---|
| JNK | State Street SPDR Bloomberg Hig | Most unusual | -0.1% | 100% of 42 sessions | Most unusual activity in this snapshot; performance direction may differ. |
| LQD | iShares iBoxx $ Investment Grad | Participating | -0.4% | 100% of 42 sessions | Price participation with distributing signed flow. |
| HYG | iShares iBoxx $ High Yield Corp | Participating | -0.1% | 100% of 42 sessions | Price participation with distributing signed flow. |
| EMB | iShares J.P. Morgan USD Emergin | Participating | -0.3% | 100% of 42 sessions | Price participation with distributing signed flow. |
04 · HAS THIS HAPPENED BEFORE
Only 3 completed episodes across 42 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.